Topical compositions containing extracellular products and uses thereof
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-031/74
A61K-035/00
A61K-039/00
A61K-039/38
A61K-039/07
A61K-035/12
A61K-035/66
A61K-035/68
A61K-035/74
A61K-035/76
A01N-063/00
A01N-025/34
A01N-025/08
A01N-063/02
C12N-001/12
C12N-001/20
출원번호
UP-0152894
(2005-06-14)
등록번호
US-7541042
(2009-07-01)
발명자
/ 주소
Farmer, Sean
출원인 / 주소
Ganeden Biotech, Inc.
대리인 / 주소
Beattie, Esq., Ingrid A.
인용정보
피인용 횟수 :
7인용 특허 :
17
초록▼
The present invention discloses compositions derived from an isolated Bacillus species, spores, or an extracellular product of Bacillus coagulans comprising a supernatant or filtrate of a culture of said Bacillus coagulans strain, suitable for topical application to the skin or mucosal membranes of
The present invention discloses compositions derived from an isolated Bacillus species, spores, or an extracellular product of Bacillus coagulans comprising a supernatant or filtrate of a culture of said Bacillus coagulans strain, suitable for topical application to the skin or mucosal membranes of a mammal, which are utilized to inhibit the growth of bacterium, yeast, fungi, virus, and combinations thereof. The present invention also discloses methods of treatment and therapeutic systems for inhibiting the growth of bacterium, yeast, fungi, virus, and combinations thereof, by topical application of therapeutic compositions which are comprised, in part, of isolated Bacillus species, spores, or an extracellular product of Bacillus coagulans comprising a supernatant or filtrate of a culture of said Bacillus coagulans strain. In addition, the present invention also discloses compositions, methods of treatment, and therapeutic systems for inhibiting the growth of bacterium, yeast, fungi, virus, and combinations thereof, comprising an extracellular product of Pseudomonas lindbergii comprising a supernatant or filtrate of a culture of said Pseudomonas lindbergii strain.
대표청구항▼
What is claimed is: 1. A composition comprising an extracellular product of a Bacillus coagulans strain and an anti-fungal agent selected from the group consisting of Amphotericin B, Carbol-Fuchsin, Ciclopirox, Clotrimzole, Econazole, Haloprogin, Ketoconazole, Mafenide, Miconazole, Naftifine, Nysta
What is claimed is: 1. A composition comprising an extracellular product of a Bacillus coagulans strain and an anti-fungal agent selected from the group consisting of Amphotericin B, Carbol-Fuchsin, Ciclopirox, Clotrimzole, Econazole, Haloprogin, Ketoconazole, Mafenide, Miconazole, Naftifine, Nystatin, Oxiconazole, Silver Sulfadiazine, Sulconazole, Terbinafine, Tioconazole, Tolnafiate, and Undecylenic acid. 2. The composition of claim 1, wherein said composition comprises approximately 0.5% to approximately 99.9% of said Emu oil, by weight. 3. The composition of claim 1, wherein said Bacillus coagulans strain is Bacillus coagulans hammer. 4. The composition of claim 1, wherein said Bacillus coagulans strain comprises Bacillus coagulans hammer ATCC Accession Number 31284. 5. The composition of claim 1, wherein said composition is in the form of an emulsion, cream, lotion, gel, oil, ointment, aerosol spray, or semi-solid formulation. 6. The composition of claim 1, wherein said extracellular product of said Bacillus coagulans strain is a culture supernatant or filtrate. 7. The composition of claim 1, wherein said composition further comprises a carrier, wherein said carrier is selected from the group consisting of trehalose, malto-dextrin, rice flour, micro-crystalline cellulose, magnesium sterate, inositol, fructo-oligosaccharide, gluco-oligosaccharide, dextrose, sucrose, talc, water, physiological salt solution, urea, methanol, ethanol, propanol, butanol, ethylene glycol, propylene glycol, white pertrolatum, isopropyl myristate, lanolin, lanolin alcohol, mineral oil, lavender oil, nasturtium extract oil, sorbitan mono-oleate, cetylstearyl alcohol, hydroxypropyl cellulose, detergent, sucrose stearate, sucrose cocoate, sucrose distearate, 2-ethyl-,1,3-hexanediol, polyoxypropylene-15-stearyl ether, glycerol stearate, glycerin, synthetic spermaceti, cetyl alcohol, butylparaben, propylparaben and methylparaben. 8. The composition of claim 1, wherein said extracellular product is a culture supernatant fractionated using a method selected from the group consisting of filtration, liquid chromatography, ion exchange chromatography, and High Performance Liquid Chromatography (HPLC). 9. A composition comprising an extracellular product of a Bacillus coagulans strain and an anti-fungal agent selected from the group consisting of Mafenide and Silver Sulfadiazine. 10. The composition of claim 9, wherein said composition comprises approximately 0.5% to approximately 99.9% of said Emu oil, by weight. 11. The composition of claim 9, wherein said Bacillus coagulans strain is Bacillus coagulans hammer. 12. The composition of claim 9, wherein said Bacillus coagulans strain comprises Bacillus coagulans hammer ATCC Accession Number 31284. 13. The composition of claim 9, wherein said composition is in the form of an emulsion, cream, lotion, gel, oil, ointment, aerosol spray, or semi-solid formulation. 14. The composition of claim 9, wherein said extracellular product of said Bacillus coagulans strain is a culture supernatant or filtrate. 15. The composition of claim 9, wherein said composition further comprises a carrier, wherein said carrier is selected from the group consisting of trehalose, malto-dextrin, rice flour, micro-crystalline cellulose, magnesium sterate, inositol, fructo-oligosaccharide, gluco-oligosaccharide, dextrose, sucrose, talc, water, physiological salt solution, urea, methanol, ethanol, propanol, butanol, ethylene glycol, propylene glycol, white pertrolatum, isopropyl myristate, lanolin, lanolin alcohol, mineral oil, lavender oil, nasturtium extract oil, sorbitan mono-oleate, cetylstearyl alcohol, hydroxypropyl cellulose, detergent, sucrose stearate, sucrose cocoate, sucrose distearate, 2-ethyl-1,3-hexanediol, polyoxypropylene-15-stearyl ether, glycerol stearate, glycerin, synthetic spermaceti, cetyl alcohol, butylparaben, propylparaben and methylparaben. 16. The composition of claim 9, wherein said extracellular product is a culture supernatant fractionated using a method selected from the group consisting of filtration, liquid chromatography, ion exchange chromatography, and High Performance Liquid Chromatography (HPLC).
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (17)
Ghosh Peter (Fairlight AUX) Whitehouse Michael (Millswood AUX) Dawson Michael (Newton AUX) Turner Athol G. (Forestville AUX), Anti-inflammatory composition derived from emu oil.
Vinopal Robert T. (Mansfield CT) Nelson ; Jr. John D. (Bethlehem CT) Glynn Michael W. (Darien CT) Coughlin Robert W. (Storrs CT) Vieth Robert F. (Manchester CT) Geiger Jon R. (West Hartford CT), Synergistic biocide composition containing pyrithione plus an additive.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.